Cassava Sciences Inc vs Sirius XM Holdings Inc — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while Sirius XM Holdings Inc trades at $26.51 (market cap $8.87B). The key difference: Sirius XM Holdings Inc is far larger — about 225.1× Cassava Sciences Inc's market cap, and Sirius XM Holdings Inc pays a 4.1% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Sirius XM Holdings Inc for 102 Days on average.
| FLNA | SIRI | |
|---|---|---|
Market Cap | $39.40M | $8.87B |
Volume | 759,018 | 4,324,672 |
Sector | Health | Media |
52-Week High | $4.64 | $32.59 |
52-Week Low | $0.68 | $19.92 |
Typical Hold Time | 37 Days | 102 Days |
Enterprise Value | -$43.28M | $18.16B |
Dividend Yield | — | 4.1% |
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.8136, down 0.26% with a bearish technical signal. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though it has beaten EPS estimates for three consecutive quarters. Recent positive FDA news regarding the clinical hold lift on simufilam for epilepsy research provides a potential catalyst. Cash flow remains negative with net cash flow of -$33.07M in 2025.
The outlook is mixed with strong analyst support (66.7% buy ratings) against fundamental challenges. Investment opportunity lies in clinical trial success, while risks include sustained cash burn and execution hurdles. The stock's low EV/EBITDA of 1.03 and P/B of 0.62 suggest undervaluation if pipeline milestones are met.
Sirius XM Holdings (SIRI) trades at $26.33, up 1.46% on the day, with a neutral technical signal and mixed earnings history. The stock shows attractive valuation metrics with a P/E of 10.57 and P/B of 0.75, while profitability remains solid with a 10.23% net margin. Recent news highlights the company's YouTube partnership potential and strong cash flow growth, with institutional buying activity noted in September 2026.
The outlook is cautiously optimistic with a consensus price target of $34.43 suggesting 31% upside, though risks include competitive pressures in audio streaming and execution on new initiatives. The company's debt reduction and stable cash generation support the bullish analyst sentiment, but investors should weigh the recent earnings misses against growth initiatives.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →